COVID-19 疫苗：Moderna 和 Pfizer-BioNTech 在城市和农村地区的使用情况各不相同。

IF 8.6 1区医学 Q1 HEALTH CARE SCIENCES & SERVICES

Health Affairs Pub Date : 2024-05-01 DOI:10.1377/hlthaff.2023.00813

Katherine Wen, Daniel A Harris, Preeti Chachlani, Kaleen N Hayes, Ellen McCarthy, Andrew R Zullo, Renae L Smith-Ray, Tanya Singh, Djeneba Audrey Djibo, Cheryl N McMahill-Walraven, Jeffrey Hiris, Rena M Conti, Jonathan Gruber, Vincent Mor

引用次数: 0

摘要

我们调查了全美医疗保险受益人使用 mRNA COVID-19 疫苗的县级差异。在城市地区，辉瑞生物技术公司的疫苗比 Moderna 疫苗的首剂和加强剂量使用率更高。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

COVID-19 Vaccines: Moderna And Pfizer-BioNTech Use Varied By Urban, Rural Counties.

We investigated county-level variation in mRNA COVID-19 vaccine use among Medicare beneficiaries throughout the United States. There was greater use of Pfizer-BioNTech vaccines than Moderna vaccines in urban areas for first and booster doses.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Health Affairs 医学-卫生保健

CiteScore

15.00

自引率

2.10%

发文量

246

审稿时长

3-6 weeks

期刊介绍： Health Affairs is a prestigious journal that aims to thoroughly examine significant health policy matters both domestically and globally. Our publication is committed to addressing issues that are relevant to both the private and public sectors. We are enthusiastic about inviting private and public decision-makers to contribute their innovative ideas in a publishable format. Health Affairs seeks to incorporate various perspectives from industry, labor, government, and academia, ensuring that our readers benefit from the diverse viewpoints within the healthcare field.